Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Featured News - Ofloxacin > Xinxiang Haibin Pharmaceutical invested 226 million yuan to rebuild the Penem series of APIs, adding imipenem and other products
— Share —

Xinxiang Haibin Pharmaceutical invested 226 million yuan to rebuild the Penem series of APIs, adding imipenem and other products

healthoo 2021-04-13
It belongs to the permitted category and has been filed with the Xinxiang High-tech Industrial Cluster Management Committee (project code: 2020- 410771-27-03-095132).

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.